Rosacea 2000

Cutis

Volumn 66, Issue 2, 2000, Pages 125-128

  Hirsch, Ranella J ^a   Weinberg, Jeffrey M ^b  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; PATHOLOGY; REVIEW; ROSACEA;

HUMANS; ROSACEA;

EID: 0034243218     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Sobye P: Etiology and pathogenesis of rosacea. Acta Derm Venereol (Stockh) 30: 137-158, 1950.
2. Tolman EL: Acne and acneiform dermatoses. In, Dermatology (Moschella SL, Hurley HJ, eds), pp 1477-1492. Philadelphia, WB Saunders, 1992.
3. Quarterman M, Johnson D, Abele C: Ocular rosacea: signs, symptoms, and tear studies before and after treatment with doxycycline. Arch Dermatol 133: 49-54, 1997.
4. deBersaques J: Historical notes on rosacea. Eur J Dermatol 5: 16-22, 1995.
5. National Rosacea Society: Now widely recognized, rosacea was first noted in 14th century. Available at: http://www.rosacea.org/art1.html. Accessed July 13, 2000.
6. Wilkin JK: Rosacea: pathophysiology and treatment. Arch Dermatol 130: 359-362, 1994.
7. Plewig G: Rosacea. In, Dermatology in General Medicine (Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, et al, eds), pp 727-735. New York, McGraw Hill, 1993.
8. Berg M, Liden S: An epidemiological study of rosacea. Acta Derm Venereol (Stockh) 69: 419-423, 1989.
9. Rebora A, Drago F, Parodi A: May Helicobacter pylori be important for dermatologists? Dermatobgy 191: 6-8, 1995.
10. Abrahamovych LI: The clinical and morphofunctional status of the esophagogastroduodenal system in patients with acne rosacea: etiological, pathogenic, and therapeutic aspects. Life Sprava 10-12: 84-88, Oct-Dec 1996.
11. Kolibasova K, Tothova I, Baumgartner J, Filo V: Eradication of Helicobacter pylori as the only successful treatment for rosacea (letter). Arch Dermatol 132: 1393, 1996.
12. Utas S, Ozbakir O, Turasan A, Utas C: Helicobacter pylori eradication treatment reduces the severity of rosacea. J Am Acad Dermatol 40: 433-435, 1999.
13. Jones M: Helicobacter pylori in rosacea: lack of an association. Arch Dermatol 134: 511, 1998.
14. Bamford JTM, Tilden RL, Blankush JL, Gangeness DE: Effect of treatment of Helicobacter pylori infection on rosacea. Arch Dermatol 135: 659-663, 1999.
15. Nanda VS: Common dermatoses. Am J Obstet Gynecol 173: 488-495, 1995.
16. Wilkin JK: Effect of subdepressor clonidine on flushing reactions in rosacea: change in malar thermal circulation index during provoked flushing reactions. Arch Dermatol 119: 211-214, 1983.
17. Witkin JK: Effect of nadolol on flushing reactions in rosacea. J Am Acad Dermatol 20: 202-205, 1989.
18. Sibbald D: Rosacea. Pharm Pract 9: 1-8, 1997.
19. Wilkin JK, Dewitt S: Treatment of rosacea: topical clindamycin vs. oral tetracycline. Int J Dermatol 32: 65-67, 1993.
20. Lebwohl MG, Medansky RS: The comparative efficacy of sodium sulfacetamide 10% sulfur 5% (Sulfacet R) lotion and metronidazole 0.75% (Metrogel) in the treatment of rosacea. J Geriatr Dermatol 3: 183-185, 1995.
21. Maddin WS, Schacter D, McElgunn PS: Open, non-comparative evaluation of topical metronidazole in the treatment of moderate to severe rosacea. Can J Dermatol 7: 740-744, 1995.
22. Aronson IK, Rumsfield JA, West DP, Alexander J, et al: Evaluation of topical metronidazole cream in acne rosacea. Drug Intell Clin Pharm 21: 346-351, 1987.
23. Dahl M, Katz H, Krueger G, et al: Topical metronidazole maintains remissions of rosacea. Arch Dermatol 34: 679-683, 1998.
24. Jorizzo J, Lebwohl M, Tobey R: The efficacy of metronidazole 1% cream once daily compared with metronidazole 1% cream twice daily and their vehicles in rosacea: a double blind clinical trial. J Am Acad Dermatol 39: 502-504, 1998.
25. Maddin S: A comparison of topical azeleic acid 20% cream and topical metronidazole 0.75% cream in the treatment of patients with papulopustular rosacea. J Am Acad Dermatol 6: 961-965, 1999.
26. Fitton A, Goa KL: Azelaic acid: a review of its pharmocological properties and therapeutic efficacy in acne and hyperpigmentary skin disorders. Drugs 41: 780-798, 1991.
27. Bleicher PA, Charles JH, Sober AJ: Topical metronidazole therapy for rosacea. Arch Dermatol 123: 609-614, 1987.
28. Erdogan E: Efficacy of low-dose isotretinoin in patients with treatment resistant rosacea. Arch Dermatol 134:884-885, 1998.
29. Laughlin SA, Dudley DK: Laser therapy in the management of rosacea. J Cutan Med Surg 2: S4-24-9, 1998.
30. Connoly CS, Bikowski J: Understanding the evolving role of lasers in rosacea therapy. Skin Aging 6: 27-28, 2000.
31. Lowe NJ, Behr KL, Fitzpatrick R, Goldman M, et al: Flashlamp pumped dye laser for rosacea-associated telangiectasia and erythema. J Dermatol Surg Oncol 17: 522-525, 1991.
32. Ross M, Watcher MA, Goodman MM: Comparison of the flashlamp pulsed dye laser with the argon tunable dye laser with robotized handpiece for facial telangiectasia. Lasers Surg Med 13: 374-378, 1993.